Collaborate with us

Amniotics is a biopharma company, dedicated to developing and bringing cell based Regenerative Medicine to the market for the benefit of patients suffering from rare and life-threatening diseases with high unmet need.

Our unique technology is based on collecting Mesenchymal Stem Cells (MSCs) from amniotic fluid collected at planned full-term caesarean sections, followed by a patent-protected enhancement of the MSCs into several kinds of tissue (or organ) targeted drug candidates for lung-, kidney-, skin- and neuronal diseases.

Moreover, we are also advancing induced pluripotent stem cells (iPSCs) for development of blood products.

We are actively looking to establish strategic partnerships with researchers and companies to enable and accelerate the development of our stem-cell-based therapies. See our pipeline here

GMP facility & CDMO services

Amniotics also works as a technology and service provider to Universities, Hospitals, and the Biopharmaceutical industry with a focus on GMP compliant manufacture of ATMPs. Amniotics work with companies to add value to their businesses by for example:

Process development for ATMPs (cell and gene therapy products) at our GMP manufacturing site in Lund, Sweden
Working with SME companies to help launch of products
Helping to solve operational challenges such as capacity constraints

If you would like to collaborate with us send an e-mail to partnering@amniotics.com